Yahoo Web Search

Search results

1. www.jazzpharma.comImproving Patients' Lives | Jazz Pharmaceuticals

   www.jazzpharma.com

   • Cached

   May 1, 2024 · Jazz Pharmaceuticals develops and commercializes medicines for rare diseases and cancers, such as biliary tract cancer and HER2-positive breast cancer. Learn more about Jazz's values, careers, and clinical trials.

   • Careers

     Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global...

     Benefits

     · Culture

     · Purpose

     · Diversity

     · FAQs

     · Stories

   • Pipeline

     OVERVIEW. JZP351, or Vyxeos ® /Vyxeos Liposomal in approved...

     Our Medicines

     · Stock Information

     · Events / Presentations

     · SEC Filings

   • About

     At Jazz Pharmaceuticals plc (NASDAQ: JAZZ), our purpose is...

     History

     · Board of Directors

     · Leadership

     · Contact Us

     · Global Footprint

     · Corporate Development

   • Investors

     Investor Contacts. Andrea N. Flynn, Ph.D. Vice President,...

     Annual Reports

     · Quarterly Results

     · Other Information

     · Analyst Coverage

     · Email Alerts

   • Our Purpose

     Jazz Pharmaceuticals recognizes that many patients today...

     Corporate Giving

     · Medical Education

     · Patient Support

     · Patient Resources

     · Ethical Standards

   • News

     Jazz Pharmaceuticals plc. Send Email Ireland: +353 1 637...

   • Drug Safety

     Sativex is marketed in the UK by Jazz. If you are a medical...

   • Clinical Trials

     As part of Jazz’s commitment to putting patients first, we...

   • Non-Interventional Studies

     Jazz Pharmaceuticals is committed to the advancement of...

   • GW Cannabinoid Platform

     GW Cannabinoid Platform Cannabinoid science has opened the...

2. en.wikipedia.org › wiki › Jazz_PharmaceuticalsJazz Pharmaceuticals - Wikipedia

   en.wikipedia.org › wiki › Jazz_Pharmaceuticals

   • Cached

   Jazz Pharmaceuticals plc (a merger of Jazz Pharmaceuticals, Inc. and Azur Pharma plc) is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States.

   • Number of employees: ~1,210 (February 2018)
   • Key people: Bruce C. Cozadd, (Chairman & CEO)

   • Founded: March 2005; 18 years ago in California, U.S.

3. Top Stories

   • 
     Seeking Alpha on MSN.com

     Avadel gains for a second day as analysts see it prevailing in case vs Jazz/FDA

     Avadel Pharmaceuticals (NASDAQ:AVDL) has gained 17% over the past two trading sessions in the wake of hearing over the Federal Drug Administration's approval for a sleep disorder drug that is the subject of patent dispute with Jazz Pharmaceuticals (NASDAQ:JAZZ).

     11 hours ago

   • 

     Business Insider

     Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews

     2 weeks ago

   • 

     Seeking Alpha on MSN.com

     Avadel Pharma gains during hearing over dispute on FDA approval of a sleep disorder drug

     3 days ago

   • 

     YAHOO!Finance

     Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript

     7 days ago

   • news.bloomberglaw

     Jazz Pharma to Fight FDA in Court Over Rival Sleep Drug Approval

     5 days ago

   View all

4. finance.yahoo.com › quote › JAZZJazz Pharmaceuticals plc (JAZZ) Stock Price, News, Quote ...

   finance.yahoo.com › quote › JAZZ

   • Cached

   Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally.

5. investor.jazzpharma.com › news-releases › newsJazz Pharmaceuticals Completes Zanidatamab Biologics License ...

   investor.jazzpharma.com › news-releases › news

   • Cached

   Apr 2, 2024 · DUBLIN, April 2, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the HER2-targeted bispecific antibody zanidatamab as a treatment for ...

6. People also ask

   Who is Jazz Pharmaceuticals?

   • Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully. By unlocking biopharmaceutical discoveries to develop novel medicines, we are giving thousands of people around the world the opportunity to redefine what’s possible.

   Improving Patients' Lives | Jazz Pharmaceuticals

   www.jazzpharma.com/

   See all results for this question

   When did Jazz Pharmaceuticals merge with Azur Pharma?

   • On September 19, 2011, Jazz Pharmaceuticals merged with Irish Azur Pharma plc to form Jazz Pharmaceuticals plc. The Azur Pharma seat in Dublin became the headquarters of the combined company.

   Jazz Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Jazz_Pharmaceuticals

   See all results for this question

   How much did jazz buy GW Pharmaceuticals?

   • In January 2021, Jazz announced it would acquire GW Pharmaceuticals for US$7.2 billion at $220 per ADR - $200.00 in cash and $20.00 in shares of Jazz. The following is an illustration of the company's mergers, acquisitions, spin-offs and historical predecessors:

   Jazz Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Jazz_Pharmaceuticals

   See all results for this question

   When will Jazz Pharmaceuticals present or publish 8 abstracts at ASCO 2024?

   • DUBLIN, April 24, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with its partners, will present or publish eight abstracts at the American Society of Clinical Oncology (ASCO) Annual Meeting from May 31-June 4, 2024 in Chicago.

   Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipelin…

   finance.yahoo.com/news/jazz-pharmaceuticals-present-data-across-200500736.html

   See all results for this question

7. finance.yahoo.com › news › jazz-pharmaceuticalsJazz Pharmaceuticals Announces Full Year and Fourth Quarter ...

   finance.yahoo.com › news › jazz-pharmaceuticals

   • Cached

   Feb 28, 2024 · Jazz Pharmaceuticals reported total revenues of $3.8 billion and net income of $414 million in 2023, driven by growth in Xywav, Epidiolex and Rylaze. The company expects double-digit revenue growth in 2024, based on multiple late-stage pipeline catalysts, including zanidatamab in biliary tract cancer.

8. news.bloomberglaw.com › health-law-and-businessJazz Pharma to Fight FDA in Court Over Rival Sleep Drug Approval

   news.bloomberglaw.com › health-law-and-business

   • Cached

   4 days ago · Jazz Pharmaceuticals PLC will take to the US District Court for the District of Columbia to argue its case against the Food and Drug Administration on whether the agency violated the Orphan Drug Act when it approved Avadel CNS Pharmaceuticals LLC’s Lumryz, a rival product of Jazz’s narcolepsy drug Xywav. At issue before the court is whether ...

9. finance.yahoo.com › news › jazz-pharmaceuticalsJazz Pharmaceuticals to Present Data Across Growing Oncology ...

   finance.yahoo.com › news › jazz-pharmaceuticals

   • Cached

   Apr 24, 2024 · DUBLIN, April 24, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company, along with its partners, will present or publish eight abstracts at the American ...

10. Videos

    • 

      9:00

      youtube.com

      Jazz Pharmaceuticals - Nothing Small About It SCLC Online Program

      Sep 3, 2021

      338 Views

    • 

      1:04

      youtube.com

      Jazz Pharmaceuticals buys GW Pharma for $7.2 billion

      Feb 3, 2021

      2.3K Views

    • 

      benzinga.com

      Why Is Jazz Pharmaceuticals (JAZZ) Stock Is Sliding Today? - Jazz Pharmaceuticals (NASDAQ:JAZZ)

      Dec 22, 2023

      0 Views

    View all